|Bid||569.33 x 1200|
|Ask||569.84 x 1000|
|Day's range||563.66 - 571.15|
|52-week range||475.77 - 618.36|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||28.70|
|Earnings date||26 Apr 2023 - 01 May 2023|
|Forward dividend & yield||1.20 (0.21%)|
|Ex-dividend date||14 Dec 2022|
|1y target est||646.12|
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $562.97, marking a +1.41% move from the previous day.
Thermo Fisher's (TMO) latest collaboration with ArsenalBio supports the latter's clinical manufacturing of autologous T-cell therapies for advanced cancer treatment.
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.